Prosthetic joint infection due to Mycobacterium xenopi: a review of the literature with a new case report.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 01 03 2019
accepted: 07 05 2019
pubmed: 18 5 2019
medline: 3 4 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

Extrapulmonary infections due to M. xenopi, particularly osteoarticular localizations, are rare. The purpose of this paper is to describe a case of prosthetic hip infection and to review the published literature on cases of M. xenopi osteoarticular infections. Literature search was performed in the following databases: MEDLINE (PubMed), Embase, Central (the Cochrane Library 2019, Issue 1), LILACS (BIREME) (Latin American and Caribbean Health Science Information database) and Clinical Trials databases (14th August 2018). We included all case reports and case series on adult patients diagnosed with bone or joint infection by M. xenopi for whom the treatment and outcome were specified. We retrieved 30 cases published between 1982 and 2012, among which 25 (83.3%) were reported from Europe. The two most common infection sites were spine (12/30, 40%) and knee (9/30, 30%). Risk factors for infection were previous invasive procedures (11/30, 36.7%), autoimmune disease (8/30, 26.7%), AIDS (4/30, 13.3%) and other comorbidities (2/30, 6.7%); five patients had no past medical history. All patients were treated with antibiotic combinations, but composition and duration of regimens hugely varied. Surgical intervention was performed in 16 patients (53.3%). Only 11 patients obtained full recovery of articular mobility after treatment. This work highlights the difficulties in diagnosing and treating M. xenopi osteoarticular infections. Globally, evidence supporting the best practice for diagnosis and treatment of this infection is scanty.

Identifiants

pubmed: 31098926
doi: 10.1007/s15010-019-01318-1
pii: 10.1007/s15010-019-01318-1
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-171

Références

Schwabacher H. A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man. J Hyg. 1959;57:57–67.
doi: 10.1017/S0022172400019896
Marks J, Schwabacher H. Infection due to Mycobacterium xenopei. Br med J. 1965;1:32–3.
doi: 10.1136/bmj.1.5426.32
Simor AE, Salit IE, Vellend H. The role of Mycobacterium xenopi in human disease. Am Rev Respir Dis. 1984;129:435–8. https://doi.org/10.1164/arrd.1984.129.3.435 .
doi: 10.1164/arrd.1984.129.3.435 pubmed: 6703502
Hoefsloot W, van Ingen J, Andrejak C, Nontuberculous Mycobacteria Network European Trials Group, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42:1604–13. https://doi.org/10.1183/09031936.00149212 .
doi: 10.1183/09031936.00149212 pubmed: 23598956
Astagneau P, Desplaces N, Vincent V, et al. Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak. Lancet. 2001;358:747–51.
doi: 10.1016/S0140-6736(01)05843-3
Feldmann JL, Menkes CJ, Le Charpentier Y, et al. Osteoarthritis of the knee caused by Mycobacterium xenopi (Osteoarthritis of the knee caused by Mycobacterium xenopi). Rev Rhum Mal Osteoartic. 1982;49:459–61.
pubmed: 7112024
Feyen J, Martens M, Mulier JC. Infection of the knee joint with Mycobacterium xenopi. Clin Orthop Relat Res. 1983;179:189–90.
doi: 10.1097/00003086-198310000-00028
Prosser AJ. Spinal infection with Mycobacterium xenopi. Tubercle. 1986;67:229–32.
doi: 10.1016/S0041-3879(86)80030-7
Rahman MA, Phongsathorn V, Hughes T, et al. Spinal infection by Mycobacterium xenopi in a non-immunosuppressed patient. Tuber Lung Dis. 1992;73:392–5. https://doi.org/10.1016/0962-8479(92)90047-N .
doi: 10.1016/0962-8479(92)90047-N pubmed: 1292722
Miller WC, Perkins MD, Richardson WJ, et al. Pott’s disease caused by Mycobacterium xenopi: case report and review. Clin Infect Dis. 1994;19:1024–8.
doi: 10.1093/clinids/19.6.1024
Coombes GM, Teh LS, Denton J, et al. Mycobacterium xenopi—an unusual presentation as tenosynovitis of the wrist in an immunocompetent patient. Br J Rheumatol. 1996;35:1008–10.
doi: 10.1093/rheumatology/35.10.1008
Froideveaux D, Claudepierre P, Brugières P, et al. Iatrogenically induced spondylodiskitis due to Mycobacterium xenopi in an immunocompetent patient. Clin Infect Dis. 1996;22:723–4.
doi: 10.1093/clinids/22.4.723
Roche B, Rozenberg S, Cambau E, et al. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. Rev Rhum Engl Ed. 1997;64:64–5.
pubmed: 9051864
Telgt DS, van den Hoogen FH, Meis JF, et al. Arthritis and spondylodiscitis caused by Mycobacterium xenopi in a patient with systemic lupus erythematosus. Br J Rheumatol. 1997;36:1025–6.
doi: 10.1093/rheumatology/36.9.1025
Ollagnier E, Fresard A, Guglielminotti C, et al. Osteoarticular Mycobacterium xenopi infection (Infection osteo-articulaire a Mycobacterium xenopi). Presse Med. 1998;27:800–3.
pubmed: 9767883
Rutten M, van den Berg JC, van den Hoogen FH, et al. Nontuberculous mycobacterial bursitis and arthritis of the shoulder. Skelet Radiol. 1998;27:33–5.
doi: 10.1007/s002560050332
Yuen K, Fam AG, Simor A. Mycobacterium xenopi arthritis. J Rheumatol. 1998;25:1016–8.
pubmed: 9598912
Kelly M, Thibert L, Sinave C. Septic arthritis in the knee due to Mycobacterium xenopi in a patient undergoing hemodialysis. Clin Infect Dis. 1999;29:1342–3. https://doi.org/10.1086/313447 .
doi: 10.1086/313447 pubmed: 10524998
Danesh-Clough T, Theis JC, van der Linden A. Mycobacterium xenopi infection of the spine: a case report and literature review. Spine. 2000;25:626–8.
doi: 10.1097/00007632-200003010-00015
Libbrecht E, Bressieux JM, Chelius P, et al. Mycobacterium xenopi osteoarthritis of the ankle in a patient followed for psoriatic rheumatism (Osteo-arthrite de cheville a Mycobacterium xenopi chez une patiente suivie pour rhumatisme psoriasique). Presse Med. 2000;29:539–40.
pubmed: 10761518
Kulasegaram R, Richardson D, Macrae B, et al. Mycobacterium xenopi osteomyelitis in a patient on highly active antiretroviral therapy (HAART). Int J STD AIDS. 2001;12:404–6. https://doi.org/10.1258/0956462011923219 .
doi: 10.1258/0956462011923219 pubmed: 11368825
Yim K, Nazeer SH, Kiska D, et al. Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanercept. Scand J Infect Dis. 2004;36:150–4.
doi: 10.1080/00365540310017474
Meybeck A, Fortin C, Abgrall S, et al. Spondylitis due to Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literature. J Clin Microbiol. 2005;43:1465–6. https://doi.org/10.1128/JCM.43.3.1465-1466.2005 .
doi: 10.1128/JCM.43.3.1465-1466.2005 pubmed: 15750135 pmcid: 1081249
Hulten EA, Hartzell J, Conrath SM, et al. Mycobacterium xenopi. A case report of a rare cause of pott disease. Infect Dis Clin Pract. 2006;14:177–80.
doi: 10.1097/01.idc.0000194285.57503.70
Salliot C, Desplaces N, Boisrenoult P, et al. Arthritis due to Mycobacterium xenopi: a retrospective study of 7 cases in France. Clin Infect Dis. 2006;43:987–93. https://doi.org/10.1086/507631 .
doi: 10.1086/507631 pubmed: 16983609
Sobottke R, Zarghooni K, Seifert H, et al. Spondylodiscitis caused by Mycobacterium xenopi. Arch Orthop Trauma Surg. 2008;128:1047–53. https://doi.org/10.1007/s00402-007-0553-y .
doi: 10.1007/s00402-007-0553-y pubmed: 18193243
Portillo ME, Sánchez F, Vicente E, et al. Trochanteric bursitis due to Mycobacterium xenopi in a patient with pharmacological immunosuppression (Bursitis trocanterea por Mycobacterium xenopi en un paciente con inmunosupresion farmacologica). Enferm Infecc Microbiol Clin. 2011;29:399–401. https://doi.org/10.1016/j.eimc.2011.01.013 .
doi: 10.1016/j.eimc.2011.01.013 pubmed: 21470717
Hartung P, Gladbach M, Richter M. Case report of a spondylitis caused by mycobacterium xenopi in a patient with rheumatoid polyarthritis and systemic lupus erythematodes. Eur Spine J. 2012;21:2387.
Salmon JH, Direz G, Ziza JM, et al. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation. Joint Bone Spine. 2012;79:409–11. https://doi.org/10.1016/j.jbspin.2012.02.001 .
doi: 10.1016/j.jbspin.2012.02.001 pubmed: 22405857
Tortoli E. Clinical manifestations of nontuberculous mycobacteria infections. Clin Microbiol Infect. 2009;15:906–10. https://doi.org/10.1111/j.1469-0691.2009.03014.x .
doi: 10.1111/j.1469-0691.2009.03014.x pubmed: 19845702
Brown-Elliot BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25:545–82. https://doi.org/10.1128/CMR.05030-11 .
doi: 10.1128/CMR.05030-11
Eid AJ, Berbari EI, Sia IG, et al. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007;45:687–94. https://doi.org/10.1086/520982 .
doi: 10.1086/520982 pubmed: 17712751
Martín-Casabona N, Bahrmand AR, Bennedsen J, Spanish Group for Non-Tuberculosis Mycobateria, et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis. 2004;8:1186–93.
pubmed: 15527150
Dailloux M, Abalain ML, Laurain C, French Mycobateria Study Group, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J. 2006;28:1211–5. https://doi.org/10.1183/09031936.00063806 .
doi: 10.1183/09031936.00063806 pubmed: 17138678
Griffith D, Aksamit T, Brown-Elliott BA, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. https://doi.org/10.1164/rccm.200604-571st .
doi: 10.1164/rccm.200604-571st pubmed: 17277290
Osmon DR, Berbari EF, Berendt AR, Infectious Diseases Society of America, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;6:e1–25. https://doi.org/10.1093/cid/cis803 .
doi: 10.1093/cid/cis803
Alfandari S. Recommandations du C-CLIN Paris Nord pour le diagnostic et le traitement des infections ostéo-articulaires à Mycobacterium xenopi. Méd Mal Infect. 1998;28:231–4.
doi: 10.1016/S0399-077X(98)80110-8
Research Committee of the British Thoracic Society. First randomized trial of treatments for pulmonary disease caused by Mycobacterium avium intracellulare, Mycobacterium malmoense, and Mycobacterium xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax. 2001;56:167–72.
doi: 10.1136/thorax.56.3.167
Jenkins PA, Campbell IA, Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium xenopi in HIV negative patients: 5 year follow-up of patients receiving standardized treatment. Respir Med. 2003;97:439–44.
doi: 10.1053/rmed.2002.1444

Auteurs

Paola Rodari (P)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy. paola.rodari@sacrocuore.it.

Stefania Marocco (S)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy.

Dora Buonfrate (D)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy.

Anna Beltrame (A)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy.

Chiara Piubelli (C)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy.

Pierantonio Orza (P)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy.

Veronica Andrea Fittipaldo (VA)

Unità di Revisioni Sistematiche e Linee Guida, Dipartimento di Oncologia, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

Zeno Bisoffi (Z)

Dipartimento di Malattie Infettive-Tropicali e Microbiologia, Centro per le Malattie Tropicali, IRCCS Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, 37024, Negrar, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH